SMAD3 and colitis: In both these models, the elevated levels of Smad7 associate with reduced Smad3 phosphorylation, and colitic mice given oral Smad7 AS show enhanced phosphorylation of Smad3, reduced synthesis of inflammatory cytokines and amelioration of colitis [38].